An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015–2018

Table 2 Characteristics of CVD Hospitalizations for Patients with Hospital-Based Diagnosis of Osteoarthritis, Gout, or Other Rheumatic Disease, Compared to No Rheumatic Disease Diagnosis

Characteristic	Osteoarthritis Only	Gout	Other Rheumatic Disease^a	No Rheumatic Disease Diagnosis
Length of stay of CVD hospitalization
<=3 days	794 (48.7%)	670 (44.4%)	253 (51.0%)	5601 (53.1%)
>3 days	835 (51.3%)**	838 (55.6%)**	243 (49.0%)	4953 (46.9%)
Discharge status
To home	1192 (78.6%)	1167 (81.2%)	381 (81.4%)	8099 (82.0%)
Other than home	324 (21.4%)**	271 (18.8%)	87 (18.6%)	1777 (18.0%)
In-hospital mortality
Discharge home	1192 (94.5%)	1167 (94.8%)	381 (93.8%)	8099 (93.4%)
Death in hospital	70 (5.5%)	64 (5.2%)	25 (6.2%)	574 (6.6%)

a: Other Rheumatic Disease includes people with a diagnosis of rheumatoid arthritis, lupus/MCTD, spondyloarthritis, vasculitis, Sjögren syndrome, systemic sclerosis, and/or myopathy. Some persons included also have osteoarthritis in addition to one or more of these conditions. Persons with gout are excluded from this category regardless of other conditions
** p < 0.01 for odds ratio comparing odds comparing two categories of discharge type or length of stay among people the rheumatic disease diagnosis to those with no rheumatic disease diagnosis

ISSN: 2520-1026